Understanding the Pathophysiology of Thrombotic APS through Animal Models
Antiphospholipid syndrome (APS) is a leading acquired cause of thrombotic events, with a notable tendency to promote thrombosis in vascular beds of all sizes, including both arterial and venous circuits. While pathogenic antiphospholipid antibodies circulate at relatively stable levels in blood, thr...
Main Authors: | Alex A. Gandhi, Shanea K. Estes, Christine E. Rysenga, Jason S. Knight |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2588 |
Similar Items
-
The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis—A Two-Year Prospective Study
by: Katja Perdan-Pirkmajer, et al.
Published: (2021-07-01) -
The Risk of Thrombotic Events in Anetoderma Affecting Young Patients
by: Chiriac Anca E., et al.
Published: (2021-06-01) -
Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
by: Savino Sciascia, et al.
Published: (2021-06-01) -
Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations
by: Manuela Velásquez, et al.
Published: (2018-12-01) -
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
by: Francisco Javier Gil-Etayo, et al.
Published: (2021-07-01)